نتائج البحث

Clinical features and prognosis of chronic natural killer cell lymphoproliferative disorders.

• Authors : Liu DL; Department of Medical Oncology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, People's Republic of China.; Wang YJ

Subjects: Epstein-Barr Virus Infections*/Epstein-Barr Virus Infections*/Epstein-Barr Virus Infections*/complications ; Lymphohistiocytosis, Hemophagocytic* ; Lymphoproliferative Disorders*/Lymphoproliferative Disorders*/Lymphoproliferative Disorders*/diagnosis

• Source: Hematology (Amsterdam, Netherlands) [Hematology] 2024 Dec; Vol. 29 (1), pp. 2307817. Date of Electronic Publication: 2024 Feb 06.Publisher: Taylor & Francis Country of Publication: England NLM ID: 9708388 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

تفاصيل العنوان

Nivolumab in Epstein-Barr Virus (EBV)-Positive Lymphoproliferative Disorders and EBV-Positive Non-HodgkinLymphomas

• Source: Phase 2 Trial of Nivolumab in Epstein-Barr Virus (EBV)-Positive Lymphoproliferative Disorders and EBV-Positive Non-Hodgkin Lymphomas

تفاصيل العنوان

An Extension Study to Evaluate the Safety and Efficacy of an Anti-CD19 CAR-T Product in Patients with B-cell Lymphoproliferative Disorders

• Source: An Open-label, Non-interventional, Single-group Follow-up Study to Evaluate the Safety and Efficacy of an Anti-CD19 CAR-T Product in Adult Patients with Relapsed or Refractory Forms of B-cell

تفاصيل العنوان

A Study to Evaluate the Tolerability, Safety, and Efficacy of an Anti-CD19 CAR-T Product in Patients with B-cell Lymphoproliferative Disorders

• Source: An Interventional Open-label, Single-group, Phase I/II Study to Evaluate the Tolerability, Safety, and Efficacy of an Anti-CD19 CAR-T Product in Adult Patients with Relapsed or Refractory Forms of

تفاصيل العنوان

Family Study of Lymphoproliferative Disorders

• Authors : National Cancer Institute (NCI); Susan Slager, Professor

• Source: Genetic Epidemiology of Lymphoproliferative DisordersSellick GS, Goldin LR, Wild RW, Slager SL, Ressenti L, Strom SS, Dyer MJ, Mauro

تفاصيل العنوان

Epcoritamab for the Treatment of Relapsed or Refractory Post Transplant Lymphoproliferative Disorders

• Authors : AbbVie; Genmab; Timothy Voorhees, Principal Investigator

• Source: Phase Ib Study to Assess the Efficacy and Safety of Epcoritamab in Relapsed or Refractory Post-Transplant Lymphoproliferative Disorder

تفاصيل العنوان

The Clinical Role of CXCR4-Targeted PET on Lymphoproliferative Disorders: A Systematic Review.

• Authors : Zamanian, Maryam¹ (AUTHOR) ; Albano, Domenico^2,3 (AUTHOR) ; Treglia, Giorgio^4,5,6 (AUTHOR)

• Source: Journal of Clinical Medicine. May2024, Vol. 13 Issue 10, p2945. 18p.

تفاصيل العنوان

SLAM Family Receptors in B Cell Chronic Lymphoproliferative Disorders.

• Authors : Kľoc, Dominik¹ (AUTHOR) ; Kurhajec, Slavomír² (AUTHOR) ; Huniadi, Mykhailo¹ (AUTHOR)

Subjects: *CELL receptors; *LYMPHOPROLIFERATIVE disorders; *T cells

• Source: International Journal of Molecular Sciences. Apr2024, Vol. 25 Issue 7, p4014. 15p.

تفاصيل العنوان

Cerebellum/liver index on baseline 18F-FDG PET/CT to improve prognostication in post-transplant lymphoproliferative disorders: a multicenter retrospective study.

• Authors : Morland, David^1,2,3,4 (AUTHOR) ; Kanagaratnam, Lukshe⁵ (AUTHOR); Hubelé, Fabrice⁶ (AUTHOR)

• Source: EJNMMI Research. 5/27/2024, Vol. 14 Issue 1, p1-10. 10p.

تفاصيل العنوان

Post-transplant lymphoproliferative disorders after allogeneic hematopoietic stem cell transplantation: a case report, meta-analysis, and systematic review.

• Authors : Su YY; Department of Hematology, Qilu Hospital of Shandong University, 107 West Wenhua Road, Jinan, Shandong, 250012, China.; Yu YF

Subjects: Epstein-Barr Virus Infections*/Epstein-Barr Virus Infections*/Epstein-Barr Virus Infections*/complications ; Hematopoietic Stem Cell Transplantation*/Hematopoietic Stem Cell Transplantation*/Hematopoietic Stem Cell Transplantation*/adverse effects ; Lymphoproliferative Disorders*/Lymphoproliferative Disorders*/Lymphoproliferative Disorders*/etiology

• Source: Diagnostic pathology [Diagn Pathol] 2024 Sep 07; Vol. 19 (1), pp. 122. Date of Electronic Publication: 2024 Sep 07.Publisher: BioMed Central Country of Publication: England NLM ID: 101251558 Publication Model: Electronic Cited Medium: Internet ISSN: 1746-1596

تفاصيل العنوان